Mgr. Marek Borský
Researcher, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 4830 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 118
2013
-
Dráha Wnt/PCP ovlivňuje kromě patogeneze chronické lymfocytární leukemie i vývoj B-lymfocytů
Year: 2013, type: Conference abstract
-
Expression of the stem cell marker nestin in leukemia cells
Year: 2013, type:
-
Mutace v genu TP53 jsou spojeny s vyšší rezistencí CLL buněk na ofatumumab a rituximab in vitro
Year: 2013, type: Conference abstract
-
Normal hematopoietic stem cells can be detected in newly diagnosed chronic myeloid leukemia patients and leukemic stem cells can be detected in CML patients after therapy by a multi-technique approach using antigen CD26.
Year: 2013, type: Conference abstract
-
Surface antigen CD26 as a marker for purification of CML stem cells
Year: 2013, type:
-
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Leukemia Research, year: 2013, volume: 37, edition: 7, DOI
-
The prospective analysis of low level BCR-ABL1 T315I mutation in the CD34+ cells of de novo CML patients
Year: 2013, type: Conference abstract
-
TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab
Year: 2013, type: Conference abstract
-
TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab
Year: 2013, type: Conference abstract
-
Wnt-PCP pathway driving pathogenesis of chronic lymphocytic leukemia participates on normal B-cell development
Year: 2013, type: Conference abstract